{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:12:52Z","timestamp":1761520372875,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.clcc.2022.07.001","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T12:50:11Z","timestamp":1657284611000},"page":"362-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Failure of Initial Curative Treatment for Non-Metastatic Anal Squamous Cell Carcinoma: From Prognostic Factors Analysis to Stratified Treatment"],"prefix":"10.1016","volume":"21","author":[{"given":"Claire","family":"Jaraudias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3963-6124","authenticated-orcid":false,"given":"Lucile Montagneb Ang\u00e9lique","family":"Saint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-9507","authenticated-orcid":false,"given":"Renaud","family":"Schiappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9a","family":"Marie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Benezery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrielle","family":"Scouarnec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9537-6454","authenticated-orcid":false,"given":"Ludovic","family":"Evesque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.clcc.2022.07.001_bib0001","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"issue":"35","key":"10.1016\/j.clcc.2022.07.001_bib0002","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clcc.2022.07.001_bib0003","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00a0\u00d7\u00a02 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"issue":"9034","key":"10.1016\/j.clcc.2022.07.001_bib0004","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research","volume":"348","year":"1996","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.clcc.2022.07.001_bib0005","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.clcc.2022.07.001_bib0006","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clcc.2022.07.001_bib0007","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/DCR.0b013e31819eb7f0","article-title":"Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base","volume":"52","author":"Bilimoria","year":"2009","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"10.1016\/j.clcc.2022.07.001_bib0008","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/annonc\/mdu188","article-title":"ACT II Study Group. Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial","volume":"25","author":"Glynne-Jones","year":"2014","journal-title":"Ann Oncol"},{"issue":"16","key":"10.1016\/j.clcc.2022.07.001_bib0009","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial","volume":"30","author":"Peiffert","year":"2012","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.clcc.2022.07.001_bib0010","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ctrv.2011.02.003","article-title":"Chemotherapy\/chemoradiation in anal cancer: a systematic review","volume":"37","author":"Lim","year":"2011","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.clcc.2022.07.001_bib0011","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00000658-199407000-00007","article-title":"Longo WE, Vernava AM 3rd, Wade TP, et\u00a0al. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy","volume":"220","year":"1994","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.clcc.2022.07.001_bib0012","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3393\/ac.2020.12.29","article-title":"Survival and Operative Outcomes After Salvage Surgery for Recurrent or Persistent Anal Cancer","volume":"36","author":"Park","year":"2020","journal-title":"Ann Coloproctol"},{"issue":"7","key":"10.1016\/j.clcc.2022.07.001_bib0013","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1245\/s10434-018-6483-9","article-title":"Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience","volume":"25","author":"Hagemans","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clcc.2022.07.001_bib0014","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijrobp.2019.10.016","article-title":"Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell Carcinoma","volume":"106","author":"Shakir","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.clcc.2022.07.001_bib0015","doi-asserted-by":"crossref","first-page":"852","DOI":"10.6004\/jnccn.2018.0060","article-title":"Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology","volume":"16","author":"Benson","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.clcc.2022.07.001_bib0016","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3349\/ymj.2013.54.1.108","article-title":"Long-term outcomes of chemoradiation for anal cancer patients","volume":"54","author":"Kim","year":"2013","journal-title":"Yonsei Med J"},{"issue":"4","key":"10.1016\/j.clcc.2022.07.001_bib0017","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2009.09.029","article-title":"Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning","volume":"78","author":"Wright","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clcc.2022.07.001_bib0018","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/COC.0000000000000673","article-title":"Determining Optimal Follow-up for Patients With Anal Cancer Following Chemoradiation","volume":"43","author":"Frazer","year":"2020","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clcc.2022.07.001_bib0019","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02303552","article-title":"Salvage abdominoperineal resection following combined chemotherapy and radiotherapy for epidermoid carcinoma of the anus","volume":"1","author":"Ellenhorn","year":"1994","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.clcc.2022.07.001_bib0020","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/BF02237294","article-title":"Results of salvage abdominoperineal resection for anal cancer after radiotherapy","volume":"41","author":"Pocard","year":"1998","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"10.1016\/j.clcc.2022.07.001_bib0021","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1046\/j.1365-2168.2002.02231.x","article-title":"Salvage abdominoperineal resection in anal epidermoid cancer","volume":"89","author":"Nilsson","year":"2002","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.clcc.2022.07.001_bib0022","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s10350-004-0548-5","article-title":"Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy","volume":"47","author":"Akbari","year":"2004","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.clcc.2022.07.001_bib0023","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1463-1318.2005.00911.x","article-title":"Salvage abdominoperineal resection after failed Nigro protocol: modest success, major morbidity","volume":"8","author":"Papaconstantinou","year":"2006","journal-title":"Colorectal Dis"},{"issue":"10","key":"10.1016\/j.clcc.2022.07.001_bib0024","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/codi.13288","article-title":"Survival following salvage abdominoperineal resection for persistent and recurrent squamous cell carcinoma of the anus: do these disease categories affect survival?","volume":"18","author":"Severino","year":"2016","journal-title":"Colorectal Dis"},{"issue":"5","key":"10.1016\/j.clcc.2022.07.001_bib0025","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000453589","article-title":"Results of Surgical Salvage Treatment for Anal Canal Cancer: A Retrospective Analysis with Overview of the Literature","volume":"34","author":"Pesi","year":"2017","journal-title":"Dig Surg"},{"issue":"2","key":"10.1016\/j.clcc.2022.07.001_bib0027","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jso.25489","article-title":"Early versus late salvage abdominoperineal resection for anal squamous cell carcinoma: Is there a difference in survival?","volume":"120","author":"Fields","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clcc.2022.07.001_bib0028","article-title":"Salvage surgery for locally recurrent anal cancer after intensity modulated radiation therapy with concurrent chemotherapy","volume":"26","author":"Bogach","year":"2021","journal-title":"Cancer Treat Res Commun"},{"issue":"12","key":"10.1016\/j.clcc.2022.07.001_bib0029","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1007\/s11605-007-0232-x","article-title":"Salvage surgery after failed chemoradiation for anal canal cancer: should the paradigm be changed for high-risk tumors?","volume":"11","author":"Stewart","year":"2007","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.clcc.2022.07.001_bib0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/bjc.2016.398","article-title":"Biomarkers in anal cancer: from biological understanding to stratified treatment","volume":"116","author":"Jones","year":"2017","journal-title":"Br J Cancer"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153300282200069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153300282200069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:08:47Z","timestamp":1761520127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153300282200069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S153300282200069X"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2022.07.001","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Failure of Initial Curative Treatment for Non-Metastatic Anal Squamous Cell Carcinoma: From Prognostic Factors Analysis to Stratified Treatment","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2022.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}